Beta Pharmaincis A Specialty Pharmaceutical Company Focused On The Discoverydevelopmentand Commercialization Of Innovative Therapiesparticularly In Oncology And Virologythe Company Is Dedicated To Improving Patient Quality Of Life By Making Advanced Treatments Accessible To Those In Need Founded From Beta Chemicalsincin 1998Beta Pharma Achieved A Significant Milestone With The Development Of Icotiniban Egfr Tyrosine Kinase Inhibitor Approved In China In 2011The Company Is Actively Working On Expanding Icotinib S Global Reach And Has Initiated Phase I Clinical Trials In The U Sbeta Pharma S Product Pipeline Emphasizes Targeted Cancer Therapiesreflecting Its Commitment To Advancing Treatment Options Led By Experienced Executivesincluding Drjirong Pengbeta Pharma Fosters A Diverse And Inclusive Workplacethe Company Is Affiliated With Several Prominent Organizations In The Fieldhighlighting Its Dedication To Cancer Research And Collaboration Within The Pharmaceutical Industry
